Daily Intelligence Brief
Zantac and Hair Relaxer Drive a Concentrated Filing Day
Two 25-filing pipelines set the day’s pace: Zantac Products Liability Litigation (2924) drew all 25 from Keller Postman LLC, while Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (3060) matched that volume behind Pulaski Kherkher PLLC’s 15 filings and Keller Postman LLC’s three. PFAS litigation stayed close behind as Aqueous Film-Forming Foams Personal Injury Products Liability Litigation (2873) added 24 cases, led by Keefe Law Firm LLC with 13 and Environmental Litigation Group PC with one. Device claims supplied a smaller but firm-concentrated channel in Covidien Hernia Mesh Products Liability Litigation (No. II) (3029), where Babin Law LLC filed all eight new cases, while Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) added four filings, including one each from Kessler Topaz Meltzer & Check LLP and Levin Papantonio. The distribution shows concentrated plaintiff-side intake across legacy pharmaceutical, consumer-product, PFAS and platform dockets rather than a broad-based surge. See the full filing feed and firm-level breakdowns here.
California Registration Cancellations Begin Paraquat Phaseout
California’s paraquat market entered a new regulatory phase on Aug. 11, when manufacturers voluntarily canceled the state registrations for their remaining paraquat-dichloride products. The action begins a statewide phaseout relevant to Paraquat Products Liability Litigation (3004), but it does not immediately remove existing stock from commerce. Products already in distribution may remain available for up to two years under California’s pesticide controls, preserving the distinction between a registration cancellation and an immediate use prohibition. The registration cancellations nonetheless reshape the current regulatory record as parties test warning, risk-management and product-feasibility theories in the Parkinson’s disease litigation.
New Jersey Enacts Youth Social-Media Restrictions
New Jersey enacted a package of youth social-media restrictions on Aug. 11, imposing stronger privacy and safety defaults for minors while limiting certain data practices, advertising and algorithmic recommendations. The enactment creates a fresh state-law benchmark for Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) as plaintiffs and defendants contest what platform safeguards were feasible and when. The measures do not decide any claimant’s injury or establish platform liability, but they sharpen the regulatory backdrop for disputes over age assurance, engagement design and youth-facing product features. Their practical significance lies in turning broad safety expectations into specific operational requirements that counsel can measure against internal platform policies and design choices.
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.